Skip to main content
Log in

The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Peripheral aromatic amino acid decarboxylase inhibitors increase human plasma 5-hydroxytryptophan (5-HTP) levels. However the 5-HTP, which is synthesized in the intestine, is not present in a sufficient quantity to influence brain 5-HT to any significant degree. Thus, peripheral decarboxylase inhibitors are unlikely to affect brain 5-HT function via 5-HTP which is synthesized peripherally.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Anderson, G. M., Purdy, W. C.: Liquid chromatographic-fluorometric system for the determination of indoles in physiological samples. Anal. Chem.51, 283–286 (1979).

    Google Scholar 

  • Chouinard, G., Young, S. N., Annable, L., Sourkes, T. L.: A controlled study of tryptophan-benserazide in schizophrenia. Commun. Psychopharmacol.2, 21–31 (1978).

    Google Scholar 

  • Fujiwara, M., Shibata, M., Nomiyama, Y., Sugimoto, T., Hirata, F., Tokuyama, T., Senoh, S., Hayaishi, O.: Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine. Proc. Natl. Acad. Sci. U.S.A.76, 1145–1149 (1979).

    Google Scholar 

  • Johnson, G. A., Gren, J. M., Kupiecki, R.: Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine). Clin. Chem.24, 1927–1930 (1978).

    Google Scholar 

  • Joseph, M. H., Baker, H. F.: The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man. Clin. Chim. Acta72, 125–131 (1976).

    Google Scholar 

  • Korf, J., Sebens, J. B., Venema, K., van Praag, H. M.: Serum levels of 5-hydroxyindole derivatives after administration of L-5-hydroxytryptophan methyl ester. Res. Commun. Chem. Path. Pharmacol.15, 171–182 (1976).

    Google Scholar 

  • Lindqvist, M., Kehr, W., Carlsson, A.: Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain. J. Neural Transm.36, 161–176 (1975).

    Google Scholar 

  • Sandler, M., Johnson, R. D., Ruthven, C. R. J., Reid, J. L., Calne, D. B.: Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition. Nature247, 364–366 (1974).

    Google Scholar 

  • Warsh, J. J., Stancer, H. C.: Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition. J. Pharmacol. Exp. Ther.197, 545–555 (1976).

    Google Scholar 

  • Waterhouse, M. J., Chia, Y. C., Lees, G. J.: Inhibition of human and rat hepatic aminotransferase activity with L-3,4-dihydroxyphenylalanine by inhibitors of peripheral aromatic amino acid decarboxylase. Mol. Pharmacol.15, 108–114 (1979).

    Google Scholar 

  • Wurtman, R. J., Watkins, C. J.: Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase. Nature265, 79–80 (1977).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Young, S.N., Gauthier, S., Chouinard, G. et al. The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels. J. Neural Transmission 53, 83–87 (1982). https://doi.org/10.1007/BF01243522

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01243522

Keywords

Navigation